Fundz

Lexeo Therapeutics Appoints Narinder Bhalla as Chief Medical Officer and José Manuel Otero as Chief Operating Officer

PUBLIC · LXEOJan 27, 2026

Position

Chief Operating Officer

Company

Lexeo Therapeutics

José Manuel Otero
New York CityBiotechnologyHealth CareGeneticsTherapeutics

Description

Lexeo Therapeutics has announced the appointment of Narinder Bhalla, MD as Chief Medical Officer and José Manuel Otero, PhD as Chief Operating Officer. These appointments are aimed at strengthening the company's expertise in cardiovascular medicine and support its strategic objectives.

Other recent leadership changes in Genetics and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Lexeo Therapeutics, and when

A new leader at Lexeo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Lexeo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lexeo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lexeo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lexeo Therapeutics

Location

345 Park Avenue South

New York City, New York, United States

About

Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lexeo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kyle
Likely contact at this company
••••••••@••••••••

See Kyle's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Lexeo Therapeutics's next move

Learn about Strategic plan

Lexeo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.